日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Author Correction: Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations

作者更正：全外显子组分析发现，中国人群中存在三个与胰腺癌风险相关的低频错义变异。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-58613-9
Chang, Jiang; Tian, Jianbo; Zhu, Ying; Zhong, Rong; Zhai, Kan; Li, Jiaoyuan; Ke, Juntao; Han, QiangQiang; Lou, Jiao; Chen, Wei; Zhu, Beibei; Shen, Na; Zhang, Yi; Gong, Yajie; Yang, Yang; Zou, Danyi; Peng, Xiating; Zhang, Zhi; Zhang, Xuemei; Huang, Kun; Yang, Ming; Wang, Li; Wu, Chen; Lin, Dongxin; Miao, Xiaoping
肿瘤免疫
肿瘤
胰腺癌
发表日期：2025
文献求助 收藏

Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy

开发用于急性髓系白血病治疗的口服、高效、选择性 CK1α 降解剂

期刊:JACS Au
影响因子:8.7
doi:10.1021/jacsau.4c00762
Huang, Lu; Chen, Lu; Chen, Lu; Peng, Bo; Zhou, Lixin; Sun, Yanli; Shi, Taiting; Lu, Jiayi; Lin, Weiye; Liu, Yuhang; Cao, Linhui; Li, Lanlan; Han, Qiangqiang; Chen, Xi; Yang, Ping; Zhang, Shuo; Wang, Zhe; Yang, Jing; Guo, Zhixiang; Jiang, Baishan; Lu, Wenchao
白血病
发表日期：2024
文献求助 收藏

A novel selective ERK1/2 inhibitor, Laxiflorin B, targets EGFR mutation subtypes in non-small-cell lung cancer.

一种新型选择性 ERK1/2 抑制剂 Laxiflorin B，靶向非小细胞肺癌中的 EGFR 突变亚型

期刊:Acta Pharmacologica Sinica
影响因子:8.4
doi:10.1038/s41401-023-01164-w
Chiang Cheng-Yao, Zhang Min, Huang Junrong, Zeng Juan, Chen Chunlan, Pan Dongmei, Yang Heng, Zhang Tiantian, Yang Min, Han Qiangqiang, Wang Zou, Xiao Tian, Chen Yangchao, Zou Yongdong, Yin Feng, Li Zigang, Zhu Lizhi, Zheng Duo
细胞生物学
肺癌
EGFR
发表日期：2024
文献求助 收藏